Thermo Fisher Scientific

Current description: Not only do we offer standalone services along any phase of the drug development journey for protein-based biologics, but we also provide integrated services — including bioprocessing, drug substance development, drug product production, and clinical pack and label. Our Path to IND...

Thermo Fisher Scientific is a leading global provider of a full suite of CDMO and CRO services as core offerings to support you from preclinical to commercial, across all major drug modalities and therapeutic areas.

From drug substance and drug product development to clinical trial resear...

Thermo Fisher Scientific offers a broad range of commercial packaging services for clients across our worldwide network of commercial facilities in the EU, United Kingdom, and United States. Our broad range of capabilities can accommodate both specialty care and primary care products to ensure that your pr...

With an expansive support network and facilities strategically located across the globe, we provide comprehensive site-to-site connectivity with dependable cold chain storage packaging/labeling, and shipment capabilities. Along with proficient monitoring and real time tracking resources, we optimize ev...

Advanced therapeutics, including cell and gene therapies, require specialized knowledge and the ability to navigate a complex, continuously evolving landscape. Therefore, it’s essential to partner with a CDMO with the experience, capacity, network, and ability to adapt and personalize its approach...

A contract research organization (CRO) supports biopharma companies by providing a wide range of early-stage drug research and development offerings, whereas a contract development and manufacturing organization (CDMO) supports sponsors by providing later-stage drug development and manufacturing services. In the pharmaceutical industry, it’s not uncommon for sponsors to independently collaborate with both a CRO and a CDMO partner at various stages of drug development, which can create unnecessary complexities and unanticipated challenges.

Our new infographic explains the benefits of working with an end-to-end, integrated CRO/CDMO partner that provides a wide range of innovative research, development, and manufacturing capabilities. It also illustrates how a single, centralized vendor can offer improved simplicity, speed, and scalability on the journey from molecule to medicine to market.